What does PHARMACIE FONZE do?

PHARMACIE FONZE is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 24 January 2002, 1 establishment.

What is the address of PHARMACIE FONZE?

The registered office of PHARMACIE FONZE is located at Rue Emile Vandervelde 30, 4624 Fléron.

Is PHARMACIE FONZE still active?

Yes. According to the CBE (16 September 2026) PHARMACIE FONZE is active, legal situation “Normale toestand”, started on 24 January 2002.

Is PHARMACIE FONZE registered on Peppol?

Yes, PHARMACIE FONZE is registered on the Peppol network with ID 0208:0476642954.

What is the enterprise number of PHARMACIE FONZE?

The enterprise number of PHARMACIE FONZE is BE0476642954.

When was PHARMACIE FONZE founded?

PHARMACIE FONZE was founded on 24 January 2002.

Who are the directors of PHARMACIE FONZE?

According to the 2025 annual accounts, the directors of PHARMACIE FONZE are: Denis FONZE.

Is PHARMACIE FONZE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 January 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE FONZE make in 2025?

PHARMACIE FONZE posted a profit after taxes of € 78,443 in financial year 2025.

What is the revenue of PHARMACIE FONZE?

As a small company, PHARMACIE FONZE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 129,669.

PHARMACIE FONZE (Private Limited) - Fléron - BE0476642954

Dossier PHARMACIE FONZE, printed on 16 September 2026 from databakkes.be/en/0476642954/pharmacie-fonze. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE FONZE from Fléron, company number BE0476642954, closed financial year 2025 with a result of € 78,443 after tax. For that financial year PHARMACIE FONZE recorded a gross margin of € 129,669 and equity of € 638,556. Compared with financial year 2024, the result moved from € 66,675 to € 78,443. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Growing

€ 638,556

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 78,443

▲ 18% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1,690

▼ 56% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 76,260 paid out

97 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 74,135

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 50,950

▼ 21% vs 2024

€ 13,889 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 1,245

▲ 95% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 23,945

▲ 14% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 111,589 Gross margin 2022: € 111,589 First fiscal year in the series	€ 119,501 Gross margin 2023: € 119,501 ▲ 7% vs 2022 (€ 111,589) Favourable step	€ 113,701 Gross margin 2024: € 113,701 ▼ 5% vs 2023 (€ 119,501) Unfavourable step	€ 129,669 Gross margin 2025: € 129,669 ▲ 14% vs 2024 (€ 113,701) Favourable step	▲ 14%
Profit after taxes	€ 64,882 Profit after taxes 2022: € 64,882 First fiscal year in the series	€ 70,211 Profit after taxes 2023: € 70,211 ▲ 8% vs 2022 (€ 64,882) Favourable step	€ 66,675 Profit after taxes 2024: € 66,675 ▼ 5% vs 2023 (€ 70,211) Unfavourable step	€ 78,443 Profit after taxes 2025: € 78,443 ▲ 18% vs 2024 (€ 66,675) Favourable step	▲ 18%
Equity	€ 589,775 Equity 2022: € 589,775 First fiscal year in the series	€ 614,726 Equity 2023: € 614,726 ▲ 4% vs 2022 (€ 589,775) Favourable step	€ 636,373 Equity 2024: € 636,373 ▲ 4% vs 2023 (€ 614,726) Favourable step	€ 638,556 Equity 2025: € 638,556 Unchanged (€ 636,373) Favourable step
Total debts	€ 56,437 Total debts 2022: € 56,437 First fiscal year in the series	€ 44,550 Total debts 2023: € 44,550 ▼ 21% vs 2022 (€ 56,437) Favourable step	€ 113,085 Total debts 2024: € 113,085 ▲ 154% vs 2023 (€ 44,550) Unfavourable step	€ 84,760 Total debts 2025: € 84,760 ▼ 25% vs 2024 (€ 113,085) Favourable step	▼ 25%
Cash	€ 3,309 Cash 2022: € 3,309 First fiscal year in the series	€ 2,733 Cash 2023: € 2,733 ▼ 17% vs 2022 (€ 3,309) Unfavourable step	€ 3,861 Cash 2024: € 3,861 ▲ 41% vs 2023 (€ 2,733) Favourable step	€ 1,690 Cash 2025: € 1,690 ▼ 56% vs 2024 (€ 3,861) Unfavourable step	▼ 56%
Retained profit	€ 583,575 Retained profit 2022: € 583,575 First fiscal year in the series	€ 608,526 Retained profit 2023: € 608,526 ▲ 4% vs 2022 (€ 583,575) Favourable step	€ 630,173 Retained profit 2024: € 630,173 ▲ 4% vs 2023 (€ 608,526) Favourable step	€ 632,356 Retained profit 2025: € 632,356 Unchanged (€ 630,173) Favourable step
Dividend	€ 76,200 Dividend 2022: € 76,200 First fiscal year in the series	€ 45,260 Dividend 2023: € 45,260 ▼ 41% vs 2022 (€ 76,200) Unchanged	€ 58,260 Dividend 2024: € 58,260 ▲ 29% vs 2023 (€ 45,260) Unchanged	€ 76,260 Dividend 2025: € 76,260 ▲ 31% vs 2024 (€ 58,260) Unchanged	▲ 31%
Bank debt	€ 28,691 Bank debt 2022: € 28,691 First fiscal year in the series	€ 9,065 Bank debt 2023: € 9,065 ▼ 68% vs 2022 (€ 28,691) Favourable step	€ 64,814 Bank debt 2024: € 64,814 ▲ € 55,749 vs 2023 (€ 9,065) Unfavourable step	€ 50,950 Bank debt 2025: € 50,950 ▼ 21% vs 2024 (€ 64,814) Favourable step	▼ 21%
Balance sheet total	€ 647,332 Balance sheet total 2022: € 647,332 First fiscal year in the series	€ 659,835 Balance sheet total 2023: € 659,835 ▲ 2% vs 2022 (€ 647,332) Unchanged	€ 753,512 Balance sheet total 2024: € 753,512 ▲ 14% vs 2023 (€ 659,835) Unchanged	€ 726,488 Balance sheet total 2025: € 726,488 ▼ 4% vs 2024 (€ 753,512) Unchanged	▼ 4%

Key figures of PHARMACIE FONZE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE FONZE?

What happened at PHARMACIE FONZE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 78,443 (▲ 18% vs 2024). Source: NBB ↗
Mar 6, 2002 New establishment in Fléron. KBO
Jan 24, 2002 Start of the company according to the CBE. KBO

In short

From € 64,882 profit in 2022 to € 78,443 profit in 2025.

Paid € 117,966 in corporate taxes since 2022.

Best year ever: 2025, with € 78,443 profit.

Paid out € 255,980 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE FONZE? We notify you, reason included.

Follow PHARMACIE FONZE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Denis FONZE

PHARMACIE FONZE

CEGEPHAR 97.2%

Behind PHARMACIE FONZE is Denis FONZE. It owns 97.2% of CEGEPHAR itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Denis FONZE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Emile Vandervelde 30

4624 Fléron

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

CEGEPHAR same network

€ 487,011 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0476.642.954

VAT number

BE 0476.642.954

Registered office

Rue Emile Vandervelde 30, 4624 Fléron

Names & denominations

PHARMACIE FONZE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

24 January 2002

Peppol

Active · Active since 20 Nov 2025

Activities · NACE

Activiteiten van holdings

Managementactiviteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE FONZE

Financials

What happened to PHARMACIE FONZE?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions